BU-NOT-SET

CONTACT US
Inhibition of 19S proteasome deubiquitinating activity in Schistosoma mansoni affects viability, oviposition, and structural changes
  • Drug substance
Eyes
Insight
The demand for antibiotics and its impact on the pharmaceutical industry since the outbreak of COVID-19
  • Industry trends
Eyes
Insight
Women in leadership
  • Corporate
Eyes
Insight
The state of the oral solid dose development and manufacturing market
  • Drug product
Eyes
Insight
Characterising APIs is Essential for Combo Drug Formulations
  • Drug substance
Eyes
Insight
Outsourcing stability testing
  • Analytical chemistry
Eyes
Insight
Brexit: What’s next for UK pharma?
  • Industry trends
Eyes
Insight
Navigating approval filings choppy international waters
  • Drug substance
Eyes
Insight
Regulatory requirements for drug substances
  • Drug substance
Product check
Insight
Insight
  • Biologics
Overcoming technical transfer challenges in virotherapy manufacturing
eBook
  • Biologics
Flexibility in gene therapy: Adapting to the unique gene therapy demands
Webinar
  • Biologics
Webinar: An optimised Plasmid DNA platform
Insight
  • Drug substance
  • Industry trends
The future of oral solid dose formulations
Insight
  • Industry trends
Trends and challenges to impact the OSD space in 2024 and beyond
Insight
  • Sustainability
Shaping pharma's carbon-reduced future
Insight
  • Sustainability
Focus on sustainability: Saving water in Bengaluru
Insight
  • Drug product
  • Drug substance
Safe handling of highly potent active pharmaceutical ingredients
White paper
  • Analytical chemistry
Development and validation of ICP-OES for trace element estimation